| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 66646 |
cas:164332-88-1，N-Boc-PEG1-bromide， [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
60 |
kx |
2024-12-18 |
| 66647 |
DOTA-Substance P DOTA-SP |
87 |
h |
2024-12-18 |
| 66648 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
76 |
zyl |
2024-12-18 |
| 66649 |
FITC-Gly-Gly-Gly-CBT |
71 |
h |
2024-12-18 |
| 66650 |
FITC-Gly-Gly-Gly-CBT |
88 |
h |
2024-12-18 |
| 66651 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne，荧光素类染料的一种 |
103 |
WYQ |
2024-12-18 |
| 66652 |
cas:98604-88-7，Bis-SS-C3-NHS ester， ADC试剂 |
82 |
kx |
2024-12-18 |
| 66653 |
DOTA-钆特酸葡甲胺 Gd-DOTA |
145 |
h |
2024-12-18 |
| 66654 |
MAL-tri-EG-OPFP的介绍 |
102 |
zyl |
2024-12-18 |
| 66655 |
NH2-PEG-NH2 氨基-聚乙二醇-氨基 |
81 |
h |
2024-12-18 |
| 66656 |
cas:1884578-00-0，Boc-Val-Ala-PAB-PNP |
77 |
kx |
2024-12-18 |
| 66657 |
CAS号为1613321-01-9的6-Azidohexanoyl-Val-Cit-PAB |
70 |
WYQ |
2024-12-18 |
| 66658 |
聚乙二醇PEG-DOTA修饰超支化聚乙烯亚胺 PEI-PEG-DOTA |
94 |
h |
2024-12-18 |
| 66659 |
DOTA修饰奥曲肽 DOTA-octreotide |
81 |
h |
2024-12-18 |
| 66660 |
CAS号为644981-35-1的Val-Cit-PAB-MMAE |
73 |
WYQ |
2024-12-18 |
| 66661 |
DOTA-KEK-(GX1)2 DOTA修饰GX1的二聚体 |
103 |
h |
2024-12-18 |
| 66662 |
cas:1639939-40-4，MC-Val-Ala-PAB-PNP， ADC试剂 |
64 |
kx |
2024-12-18 |
| 66663 |
endo BCN-PEG3-Val-Cit，CAS号：1263166-91-1 |
69 |
WYQ |
2024-12-18 |
| 66664 |
Azide-DOTA-Eu 叠氮-DOTA-Eu |
65 |
h |
2024-12-18 |
| 66665 |
CAS号：2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
73 |
WYQ |
2024-12-18 |
| 66666 |
Fe3O4@TCPP-DOTA-Ho3+ 钬固载四氧化三铁磁性纳米颗粒偶联TCPP功能化DOTA大环配体 |
67 |
h |
2024-12-18 |
| 66667 |
cas:1360436-95-8，H-DL-Phe(4-Ac)-OH·HCl， 3-(4-乙酰基苯基)-2-氨基丙酸盐酸盐 |
60 |
kx |
2024-12-18 |
| 66668 |
CAS号：2226472-28-0 DBCO-PEG4-Val-Cit-PAB-PNP |
69 |
WYQ |
2024-12-18 |
| 66669 |
PPI-DOTA 第四代聚丙烯亚胺树状大分子PPI修饰DOTA螯合剂 |
84 |
h |
2024-12-18 |
| 66670 |
Fmoc-NH-PEG9-CH2CH2COOH CAS:1191064-81-9-ADC分子 |
103 |
zyl |
2024-12-18 |
| 66671 |
四巯基功能化的聚集诱导发光分子(TPE-4SH) |
95 |
h |
2024-12-18 |
| 66672 |
cas:1807512-47-5，Mal-PEG2-PFP ester，马来酰亚胺-二聚乙二醇-五氟苯酚酯 |
76 |
kx |
2024-12-18 |
| 66673 |
单抗MN14-DOTA 大环配体DOTA修饰单抗MN14 |
71 |
h |
2024-12-18 |
| 66674 |
Oleoyl-Gly-Lys-N-(m-PEG11)烷基链 |
72 |
zyl |
2024-12-18 |
| 66675 |
DOTA-Gd-Au PENPs mPEG修饰钆螯合剂包裹金纳米粒 |
79 |
h |
2024-12-18 |
| 66676 |
Fmoc-Gly3-Val-Cit-PAB-PNP烷基链定制 |
101 |
zyl |
2024-12-18 |
| 66677 |
cas:1268488-70-5，Bis-PEG9-acid，4,7,10,13,16,19,22,25,28-九氧杂三十一烷-1,31-二酸 |
66 |
kx |
2024-12-18 |
| 66678 |
DOTA-SSTa DOTA修饰SSTa抑制剂 |
95 |
h |
2024-12-18 |
| 66679 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
65 |
WYQ |
2024-12-18 |
| 66680 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
82 |
WYQ |
2024-12-18 |
| 66681 |
cy5.5-QS cy5.5荧光标记VEGF125-136小肽QS |
72 |
h |
2024-12-18 |
| 66682 |
THP-SS-PEG1-Boc CAS:1807503-88-3 |
71 |
zyl |
2024-12-18 |
| 66683 |
cas:132178-37-1，Propargyl-C1-NHS ester，2, 5-二氧代吡咯烷-1-基 戊-4-炔酸酯 |
59 |
kx |
2024-12-18 |
| 66684 |
CAS号为646502-53-6的MC-Val-Cit-PAB-MMAE |
77 |
WYQ |
2024-12-18 |
| 66685 |
DOTA-ECL1i 7-氨基酸CCR2结合肽[外环1变型(ECL1i)]偶联DOTA大环配体 |
78 |
h |
2024-12-18 |
| 66686 |
MC-EVCit-PAB-MMAE（CAS号：2873452-49-2） |
68 |
WYQ |
2024-12-18 |
| 66687 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
63 |
h |
2024-12-18 |
| 66688 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
64 |
h |
2024-12-18 |
| 66689 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
69 |
h |
2024-12-18 |
| 66690 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
61 |
h |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询